<p>The GAVI Vaccine Alliance has signed an advanced purchase agreement with Johnson & Johnson for 200 million doses of its Covid-19 vaccine for the COVAX vaccine-sharing programme, it said in a statement on Friday.</p>.<p><a href="http://www.deccanherald.com/tag/covid-19"><strong>SPECIAL CORONAVIRUS COVERAGE ONLY ON DH</strong></a></p>.<p>GAVI said the goal was to have the doses available in 2021 and for both self-financing participants of COVAX as well as poorer countries.</p>.<p>"As a one dose vaccine, the J&J vaccine has particular relevance for places with difficult infrastructure, making it a very important addition to the portfolio," said GAVI CEO Seth Berkley.</p>
<p>The GAVI Vaccine Alliance has signed an advanced purchase agreement with Johnson & Johnson for 200 million doses of its Covid-19 vaccine for the COVAX vaccine-sharing programme, it said in a statement on Friday.</p>.<p><a href="http://www.deccanherald.com/tag/covid-19"><strong>SPECIAL CORONAVIRUS COVERAGE ONLY ON DH</strong></a></p>.<p>GAVI said the goal was to have the doses available in 2021 and for both self-financing participants of COVAX as well as poorer countries.</p>.<p>"As a one dose vaccine, the J&J vaccine has particular relevance for places with difficult infrastructure, making it a very important addition to the portfolio," said GAVI CEO Seth Berkley.</p>